122 related articles for article (PubMed ID: 1417964)
1. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
Lloret S; Moreno JJ
Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
[TBL] [Abstract][Full Text] [Related]
2. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
Märki F; Pfeilschifter J; Rink H; Wiesenberg I
FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
[TBL] [Abstract][Full Text] [Related]
3. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
Tetta C; Camussi G; Bussolino F; Herrick-Davis K; Baglioni C
J Pharmacol Exp Ther; 1991 May; 257(2):616-20. PubMed ID: 2033508
[TBL] [Abstract][Full Text] [Related]
5. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
Moreno JJ
Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiflammins on endotoxin-induced uveitis in rats.
Chan CC; Ni M; Miele L; Cordella-Miele E; Ferrick M; Mukherjee AB; Nussenblatt RB
Arch Ophthalmol; 1991 Feb; 109(2):278-81. PubMed ID: 1993038
[TBL] [Abstract][Full Text] [Related]
7. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
[TBL] [Abstract][Full Text] [Related]
8. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation.
Lloret S; Moreno JJ
Eur J Pharmacol; 1994 Nov; 264(3):379-84. PubMed ID: 7535228
[TBL] [Abstract][Full Text] [Related]
9. Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions.
Camussi G; Tetta C; Baglioni C
Adv Exp Med Biol; 1990; 279():161-72. PubMed ID: 2096695
[No Abstract] [Full Text] [Related]
10. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells.
Zouki C; Ouellet S; Filep JG
FASEB J; 2000 Mar; 14(3):572-80. PubMed ID: 10698973
[TBL] [Abstract][Full Text] [Related]
11. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of antiflammin peptides in experimental ocular inflammation.
Chan CC; Tuaillon N; Li Q; Shen DF
Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752
[TBL] [Abstract][Full Text] [Related]
14. Antiflammins: endogenous nonapeptides with regulatory effect on inflammation.
Moreno JJ
Gen Pharmacol; 1997 Jan; 28(1):23-6. PubMed ID: 9112072
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
[No Abstract] [Full Text] [Related]
16. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.
Camussi G; Tetta C; Bussolino F; Baglioni C
J Exp Med; 1990 Mar; 171(3):913-27. PubMed ID: 2137857
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins).
Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M
Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299
[No Abstract] [Full Text] [Related]
18. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
[TBL] [Abstract][Full Text] [Related]
19. Antiflammins. Bioactive peptides derived from uteroglobin.
Miele L
Ann N Y Acad Sci; 2000; 923():128-40. PubMed ID: 11193751
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
